Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3358 results

Sort By:

A Phase 2 Study to Evaluate Efficacy of Calaspargase Pegol-mknl and Decitabine Combined With Venetoclax in Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (T-ALL) and T- Cell Lymphoblastic Lymphoma (T-LLy)

Study ID: NCT06561074
Start Date: 2025-06-30
End Date: 2031-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

22

Intervention / Treatment

Decitabine

Venetoclax

CALASPARGASE PEGOL-MKNL

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Remote Orthophonic Follow-up on Patients with Chronic Swallowing Disorders

Study ID: NCT04969874
Start Date: 2025-12
End Date: 2026-09
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Remote follow-up

Sponsor

University Hospital, Toulouse

Source: clinicaltrials.gov

Share:
Add to list

XP-102 and XP-102 in Combination With Trametinib in Advanced Solid Tumor Patients With a BRAF V600 Mutation

Study ID: NCT05275374
Start Date: 2025-12-31
End Date: 2028-12-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

221

Intervention / Treatment

XP-102

Trametinib

Sponsor

Xynomic Pharmaceuticals, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Psilocybin-Assisted Therapy for Sexual Assault-Related PTSD

Study ID: NCT06902974
Start Date: 2025-08
End Date: 2027-10
Study Type

Interventional

Study Phase

Phase2

No. of Participants

35

Intervention / Treatment

Psilocybin 25 mg

Sponsor

Sunstone Medical

Source: clinicaltrials.gov

Share:
Add to list

The Development and Evaluation of a Culturally Grounded ENDS Intervention for Rural Hawaiian Youth

Study ID: NCT06929520
Start Date: 2025-10-15
End Date: 2027-05-15
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

500

Intervention / Treatment

ENDS Prevention Intervention (TBD)

Sponsor

University of Hawaii

Source: clinicaltrials.gov

Share:
Add to list

Visual Perception in Schizophrenia

Study ID: NCT06911931
Start Date: 2025-06-01
End Date: 2027-01-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

84

Intervention / Treatment

EEG measure of visual processing

Sponsor

University of Rochester

Source: clinicaltrials.gov

Share:
Add to list

Engaging Kids With Robotic Exoskeletons and Gamification

Study ID: NCT06647082
Start Date: 2025-06-30
End Date: 2026-12-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

5

Intervention / Treatment

Pediatric Knee Exoskeleton

Sponsor

Georgia Institute of Technology

Source: clinicaltrials.gov

Share:
Add to list

The Development of a Transdiagnostic Intervention to Improve Social Functioning and Intimate Relationships Among Veterans

Study ID: NCT06746727
Start Date: 2028-07-03
End Date: 2030-09-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

29

Intervention / Treatment

Acceptance and Commitment Therapy for Social Health, Achievement, and Relationship Effectiveness (ACT-SHARE)

Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list

METRIKAMIND - Development of a Digital Mental Health Ecosystem for Workplace Environments

Study ID: NCT06650176
Start Date: 2025-09-30
End Date: 2026-04-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

400

Intervention / Treatment

Lifestyle Management

Sponsor

David Gallardo-Pujol

Source: clinicaltrials.gov

Share:
Add to list

THC + CBD and Memory Study

Study ID: NCT04855526
Start Date: 2025-12-01
End Date: 2026-12-30
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

9

Intervention / Treatment

High THC/No CBD Marihuana

High THC/High CBD Marihuana

No THC/No CBD Marihuana

Sponsor

Hartford Hospital

Source: clinicaltrials.gov

Share:
Add to list